Eggertsen R
Acta Med Scand Suppl. 1984;689:1-46.
The purpose of this study was to evaluate the acute and long-term effects on blood pressure and hemodynamics both at rest and during acute exposure to loud noise of drugs with beta-adrenoceptor blocking and vasodilating properties. Prizidilol and carvedilol both act as nonselective beta-blocking and precapillary vasodilating compounds. Prizidilol (200 mg X 2) was compared to propranolol (80 mg X 2) plus hydralazine (25 mg X 2) and showed similar antihypertensive effect in a long-term double-blind randomized trial. Carvedilol was evaluated acutely with invasive (dye-dilution) and noninvasive (plethysmography) technique and showed an acute antihypertensive effect without causing a rise in TPR and with a decrease in regional resistance in the fore-arm. Acutely, carvedilol (25 mg and 50 mg) decreased blood pressure and regional resistance (50 mg) in contrast to propranolol (80 mg) which did not lower blood pressure acutely and caused an increase in regional resistance. In a long-term double-blind, randomized comparison, both propranolol (80 mg X 2) and carvedilol (25 mg X 2 and 50 mg X 2) showed a useful antihypertensive effect. After 29 days, however, it was still possible to demonstrate an acute decrease in resistance with carvedilol (50 mg) after tablet intake, indicating the vasodilating activity of this compound. When patients with essential hypertension were exposed to an even broad band noise (100 dBA), there was a rise in blood pressure due to an increase in TPR. Alpha 1-adrenoceptor blockade (prazosin 2 mg) prevented the rise in TPR but blood pressure increased in spite of this due to a rise in CO. Moreover, nonselective beta-adrenoceptor blockade and alpha 1-adrenoceptor blockade in combination (labetalol 200 mg) were unable to prevent the rise in blood pressure induced by noise. Finally, precapillary vasodilatation and beta-adrenoceptor blockade (prizidilol 400 mg) given as long-term treatment were also inefficient in preventing the noise-induced (105 dBA) rise in blood pressure. The absolute level of blood pressure obtained, however, was significantly lower than during placebo administration.
本研究的目的是评估具有β-肾上腺素能受体阻断和血管舒张特性的药物对静息状态以及急性暴露于高强度噪声时的血压和血流动力学的急性和长期影响。普齐地洛和卡维地洛均为非选择性β受体阻滞剂和毛细血管前血管扩张剂。在一项长期双盲随机试验中,将普齐地洛(200 mg×2)与普萘洛尔(80 mg×2)加肼屈嗪(25 mg×2)进行比较,结果显示二者具有相似的降压效果。采用有创(染料稀释法)和无创(体积描记法)技术对卡维地洛进行急性评估,结果显示其具有急性降压作用,不会导致总外周阻力(TPR)升高,且前臂局部阻力降低。急性给药时,卡维地洛(25 mg和50 mg)可降低血压和局部阻力(50 mg),而普萘洛尔(80 mg)则不会急性降低血压,反而会导致局部阻力增加。在一项长期双盲随机比较中发现,普萘洛尔(80 mg×2)和卡维地洛(25 mg×2和50 mg×2)均具有有效的降压作用。然而,29天后,仍可证明服用卡维地洛(50 mg)片剂后局部阻力会急性降低,这表明该化合物具有血管舒张活性。原发性高血压患者暴露于宽带噪声(100 dBA)时,由于TPR增加,血压会升高。α1-肾上腺素能受体阻断(哌唑嗪2 mg)可防止TPR升高,但尽管如此,由于心输出量(CO)增加,血压仍会升高。此外,非选择性β-肾上腺素能受体阻断与α1-肾上腺素能受体阻断联合使用(拉贝洛尔200 mg)无法防止噪声引起的血压升高。最后,长期给予毛细血管前血管扩张剂和β-肾上腺素能受体阻断剂(普齐地洛400 mg)也无法有效防止噪声(105 dBA)引起的血压升高。然而,所获得的血压绝对水平显著低于服用安慰剂时的水平。